Pfizer, BioNtech say flu-COVID shot generates robust immune reaction in trial
Pfizer and BioNTech stated on Thursday that their vaccine to forestall flu and COVID-19 generated a robust immune reaction towards lines of the viruses in an early- to mid-stage trial. (Johanna Geron,